Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: A pilot study

A combination chemotherapy with low dose

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

✍ Shin-ichiro Kuriya; Kazunori Murai; Yasuro Miyairi; Taiju Utsugisawa; Yasushi Na 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 1 views

## BACKGROUND. Even now, no definitely effective therapy is inducted to high risk myelodysplastic syndromes (MDS) and their leukemic stage (MDS-AML) except bone marrow transplantation. ## METHODS. Ten patients with high risk MDS and 6 with MDS-AML were treated with daily low doses of cytarabine